Belite Bio, Inc American Depositary Shares
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BLTE and other ETFs, options, and stocks.About BLTE
Belite Bio, Inc. engages in the research and development of drugs. It focuses on the treatment of eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease.
CEOYue Hsin Lin
CEOYue Hsin Lin
Employees25
Employees25
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2018
Founded2018
Employees25
Employees25
BLTE Key Statistics
Market cap5.44B
Market cap5.44B
Price-Earnings ratio-80.99
Price-Earnings ratio-80.99
Dividend yield—
Dividend yield—
Average volume270.44K
Average volume270.44K
High today$156.00
High today$156.00
Low today$153.00
Low today$153.00
Open price$154.31
Open price$154.31
Volume25.88K
Volume25.88K
52 Week high$162.00
52 Week high$162.00
52 Week low$49.00
52 Week low$49.00
Stock Snapshot
With a market cap of 5.44B, Belite Bio, Inc American Depositary Shares(BLTE) trades at $155.84. The stock has a price-to-earnings ratio of -80.99.
On 2025-12-23, Belite Bio, Inc American Depositary Shares(BLTE) stock moved within a range of $153.00 to $156.00. With shares now at $155.84, the stock is trading +1.9% above its intraday low and -0.1% below the session's peak.
Trading volume for Belite Bio, Inc American Depositary Shares(BLTE) stock has reached 25.88K, versus its average volume of 270.44K.
The stock's 52-week range extends from a low of $49.00 to a high of $162.00.
The stock's 52-week range extends from a low of $49.00 to a high of $162.00.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%